BioNTech SE (BNTX) Interest Coverage Ratio (2018 - 2025)
BioNTech SE (BNTX) reported Interest Coverage Ratio of 76.86 for Q4 2025, up 751.68% on a YoY basis from 9.02 in Q4 2024, and up 4029.64% sequentially from 1.86 in Q3 2025.
BioNTech SE (BNTX) Interest Coverage Ratio (2018 - 2025) Analysis & Trends
BioNTech SE (BNTX) has 8 years of Interest Coverage Ratio data on file, last reported at 76.86 in Q4 2025.
- For the quarter ending Q4 2025, Interest Coverage Ratio rose 751.68% year-over-year to 76.86; the trailing twelve-month figure through Dec 2025 stood at 20.01 (down 50.41% YoY), and the FY2025 full-year result was 20.13, down 58.04% from the prior year.
- Interest Coverage Ratio advanced to 76.86 in Q4 2025, from 1.86 in the prior quarter.
- In the past five years, Interest Coverage Ratio ranged from a high of 433.31 in Q2 2023 to a low of 819.43 in Q2 2022.
- A 5-year average of 120.84 and a median of 6.55 in 2024 frame the typical range for Interest Coverage Ratio.
- Across the five-year window, Interest Coverage Ratio sank 14108.06% in 2021 and soared 751.68% in 2025, its largest moves.
- Tracing BNTX's Interest Coverage Ratio over 5 years: stood at 770.44 in 2021, then soared by 97.31% to 20.7 in 2022, then slipped by 0.89% to 20.88 in 2023, then jumped by 43.52% to 11.79 in 2024, then soared by 751.68% to 76.86 in 2025.
- Business Quant data shows BNTX's Interest Coverage Ratio at 76.86 in Q4 2025, 1.86 in Q3 2025, and 71.59 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 658.42 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 7.60 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -0.22 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 2.71 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 22.72 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -0.38 |
| 10 | BioNTech SE | 22.13 Bn | 22.13 Bn | 668.28 Mn | 76.86 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 76.86 |
| Sep 30, 2025 | 1.86 |
| Jun 30, 2025 | 71.59 |
| Mar 31, 2025 | 15.76 |
| Dec 31, 2024 | -11.79 |
| Sep 30, 2024 | -1.31 |
| Jun 30, 2024 | 132.36 |
| Mar 31, 2024 | 107.91 |
| Dec 31, 2023 | -20.88 |
| Sep 30, 2023 | -36.55 |
| Jun 30, 2023 | 433.31 |
| Mar 31, 2023 | -22.57 |
| Dec 31, 2022 | -20.70 |
| Sep 30, 2022 | -742.14 |
| Jun 30, 2022 | -819.43 |
| Mar 31, 2022 | -814.49 |
| Dec 31, 2021 | -770.44 |
| Sep 30, 2021 | -57.12 |
| Jun 30, 2021 | 23.87 |
| Mar 31, 2021 | 37.19 |